S. Claiborne Johnston

机构：University of California, San Francisco · ORCID：0000-0002-2912-0714

发表论文 545 篇 · 总被引 58342 次 · h-index 106

代表论文

• Dual Antiplatelet Treatment up to 72 Hours after Ischemic Stroke (2023 · New England Journal of Medicine · 被引 154)
• Colchicine in patients with acute ischaemic stroke or transient ischaemic attack (CHANCE-3): multicentre, double blind, randomised, placebo controlled trial (2024 · BMJ · 被引 95)
• Milvexian vs apixaban for stroke prevention in atrial fibrillation: The LIBREXIA atrial fibrillation trial rationale and design (2024 · American Heart Journal · 被引 36)
• Indobufen versus aspirin in patients with acute ischaemic stroke in China (INSURE): a randomised, double-blind, double-dummy, active control, non-inferiority trial (2023 · The Lancet Neurology · 被引 34)
• Oral factor xia inhibitor milvexian after a recent acute coronary syndrome: Rationale and design of the phase 3 (Librexia ACS) (2025 · American Heart Journal · 被引 16)
• Dual Antiplatelet Therapies and Causes in Minor Stroke or Transient Ischemic Attack: A Prespecified Analysis in the CHANCE-2 Trial (2023 · Stroke · 被引 15)